The Science and Technology Equity Composite seeks long-term capital appreciation by investing in companies expected to benefit from the development, advancement, and use of science and/or technology.
- Seeks long-term capital appreciation by investing in companies expected to benefit from the development and use of science or technology, focusing on high-quality business models that have the potential to sustain above-average earnings growth
- Invests behind key investment themes such as Internet commerce, Internet advertising, cloud computing, and artificial intelligence
- Bottom-up stock selection is based on rigorous analysis of individual companies, sectors, and industry trends
- Supported by deep and dedicated analytical resources that span technology, consumer discretionary, communication services, industrials, and healthcare sectors, as well as geographies
- Typically 50-70 stock portfolio
- Position size varies based on conviction in the stock, with the top ten holdings generally comprising 35-40% of the portfolio
- Diversified across sectors that are affected by science and technology, including stocks classified in the technology, consumer discretionary, communication services, industrials, and healthcare sectors
- Industry allocations are a by-product of our bottom-up stock selection process
|1 YR||3 YR
|Composite Gross %||27.92%||20.56%||20.18%||19.39%|
|Composite Net %||27.17%||19.85%||19.48%||18.69%|
|Excess Return (Gross) %||4.69%||0.18%||2.19%||1.88%|
|3 MonthsData as of 30-Jun-2020||Year to DateData as of 30-Jun-2020|
|Composite Gross %||30.60%||10.12%|
|Composite Net %||30.42%||9.79%|
|Excess Return (Gross) %||-0.01%||-0.94%|
Past performance is not a reliable indicator of future performance.
Returns for time periods greater than one year are annualised.
Gross performance returns are presented before management and all other fees, where applicable, but after trading expenses. Net of fees performance reflects the deduction of the highest applicable management fee that would be charged based on the fee schedule contained within this material, without the benefit of breakpoints. Gross and net performance returns reflect the reinvestment of dividends and are net of all non-reclaimable withholding taxes on dividends, interest income, and capital gains.
Lam Research (N)1.37%
Ken Allen is a portfolio manager in the U.S. Equity Division. He is chairman of the Investment Advisory Committee of the Science & Technology Equity Strategy and a vice president and an Investment Advisory Committee member of the US Quantitative U.S., Diversified Mid-Cap Growth Equity, U.S. Mid-Cap Growth Equity, Global Technology Equity, U.S. Large Cap Value Equity and US Quantitative Efficient Strategies . Ken is a vice president of T. Rowe Price Group, Inc., and T. Rowe Price International Funds.
Ken’s investment experience began in 2000 when he joined T. Rowe Price, beginning in the U.S. Equity Division.
Ken earned a B.A. in economics from Colby College.
- Portfolio manager2008
- Years at20
T. Rowe Price
- Years investment20